We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Vegetables Found to Enhance DNA Repair

By Biotechdaily staff writers
Posted on 21 Feb 2006
A new study reveals that various vegetables contain chemicals that appear to enhance DNA repair in cells, which could lead to protection against the development of cancer.

In a study published in the February 2006 issue of the British Journal of Cancer, investigators demonstrated that in laboratory tests, a compound called indole-3-carinol (I3C), found in broccoli, cauliflower, and cabbage, and a chemical called genistein, found in soy beans, can increase the levels of BRCA1 and BRCA2 proteins that repair damaged DNA.

Although the health benefits of eating vegetables--particularly cruciferous ones, such as broccoli--are not especially new, this study is one of the first to provide a molecular explanation as to how consuming vegetables could slash an individual's risk of developing cancer, an association found by the study's senior author, Eliot M. More...
Rosen, M.D., Ph.D., professor of oncology, cell biology, and radiation medicine at Lombardi Comprehensive Cancer Center at Georgetown University (Washington DC, USA). "It is now clear that the function of crucial cancer genes can be influenced by compounds in the things we eat,” Dr. Rosen noted. "Our findings suggest a clear molecular process that would explain the connection between diet and cancer prevention.”

In this study, Rosen exposed breast and prostate cancer cells to increasing amounts of 13C and genistein, and discovered that these chemicals enhanced production of BRCA1, as well as its sister repair protein, BRCA2. Mutations in either of these genes can lead to development of breast, prostate, and ovarian cancers.

Because decreased amounts of the BRCA proteins are seen in cancer cells, higher levels might prevent cancer from developing, according to Dr. Rosen, adding that the ability of I3C and genistein to increase production of BRCA proteins could explain their protective effects.



Related Links:
Georgetown University

Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Procalcitonin Test
LIAISON B•R•A•H•M•S PCT II GEN
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.